The South African vaccine producer Biovac has announced a major expansion of its Cape Town operations. This is a significant development in African vaccine manufacturing. This ambitious project receives significant backing from the European Investment Bank (EIB) Group and the International Finance Corporation (IFC). The new financing package will help Biovac develop end-to-end production capabilities. The primary focus will initially…
Tag: Health Security
-
Lenacapavir Manufacturing In SA: Strengthening Production
A new wave of “America First” industrial policy is reshaping global supply chains. Medicines and vaccines are increasingly treated as strategic assets, not just commercial products. That shift matters for South Africa, which still relies heavily on imports for essential health technologies, making discussions around Lenacapavir Manufacturing in SA increasingly important. The COVID-19 pandemic exposed how quickly supply lines can…
-
African Pharmaceutical Procurement: A Path to Self-Sufficiency
A pooled system for African pharmaceutical procurement is crucial. Africa must reduce its dependence on imported medicines. Delegates at a G20 event reached this conclusion. The discussion highlighted Africa’s vulnerability in its supply chain. The COVID-19 pandemic exposed this. Recent US and European aid cuts emphasised this. The Need for African Pharmaceutical Procurement Africa’s lack of local production is a…